Dipeptidyl peptidase-4 inhibitor cardiovascular safety in patients with type 2 diabetes, with cardiovascular and renal disease: a retrospective cohort study. uri icon

authors

  • Baksh, Sheriza
  • Wen, Jiajun
  • Mansour, Omar
  • Chang, Hsien-Yen
  • McAdams-DeMarco, Mara
  • Jodi Segal, MD, MPH
  • Ehrhardt, Stephan
  • Alexander, G Caleb

publication date

  • August 17, 2021